Lupin gets USFDA nod to market generic diabetes drug
The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application for Dapagliflozin and Saxagliptin tablets, the Mumbai-based drug maker said in a regulatory filing.
This generic product will be manufactured at its Pithampur facility, the company said. Image Courtesy: Reuters.